Annual CFF
$515.26 M
+$63.73 M+14.11%
December 31, 2024
Summary
- As of March 12, 2025, GPCR annual cash flow from financing activities is $515.26 million, with the most recent change of +$63.73 million (+14.11%) on December 31, 2024.
- During the last 3 years, GPCR annual CFF has risen by +$412.01 million (+399.02%).
- GPCR annual CFF is now at all-time high.
Performance
GPCR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$615.00 K
+$1.37 M+181.24%
December 31, 2024
Summary
- As of March 12, 2025, GPCR quarterly cash flow from financing activities is $615.00 thousand, with the most recent change of +$1.37 million (+181.24%) on December 31, 2024.
- Over the past year, GPCR quarterly CFF has increased by +$1.37 million (+181.24%).
- GPCR quarterly CFF is now -99.88% below its all-time high of $514.70 million, reached on June 30, 2024.
Performance
GPCR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$515.26 M
-$281.01 M-35.29%
December 31, 2024
Summary
- As of March 12, 2025, GPCR TTM cash flow from financing activities is $515.26 million, with the most recent change of -$281.01 million (-35.29%) on December 31, 2024.
- Over the past year, GPCR TTM CFF has dropped by -$281.01 million (-35.29%).
- GPCR TTM CFF is now -35.39% below its all-time high of $797.51 million, reached on June 30, 2024.
Performance
GPCR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GPCR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.1% | +181.2% | -35.3% |
| 3 y3 years | +399.0% | +181.2% | -35.3% |
| 5 y5 years | +1894.3% | +181.2% | -35.3% |
GPCR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1675.9% | -99.9% | +142.5% | -35.4% | >+9999.0% |
| 5 y | 5-year | at high | +1894.3% | -99.9% | +142.5% | -35.4% | >+9999.0% |
| alltime | all time | at high | +1894.3% | -99.9% | +142.5% | -35.4% | >+9999.0% |
Structure Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $515.26 M(+14.1%) | $615.00 K(-181.2%) | $515.26 M(-35.3%) |
| Sep 2024 | - | -$757.00 K(-100.1%) | $796.28 M(-0.2%) |
| Jun 2024 | - | $514.70 M(>+9900.0%) | $797.51 M(+182.3%) |
| Mar 2024 | - | $702.00 K(-99.8%) | $282.51 M(-37.4%) |
| Dec 2023 | $451.53 M | $281.63 M(>+9900.0%) | $451.53 M(+166.3%) |
| Sep 2023 | - | $473.00 K(-259.3%) | $169.59 M(+0.4%) |
| Jun 2023 | - | -$297.00 K(-100.2%) | $168.85 M(-15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $169.73 M(<-9900.0%) | $200.19 M(+590.0%) |
| Dec 2022 | $29.01 M(-71.9%) | -$316.00 K(+22.0%) | $29.01 M(-1.1%) |
| Sep 2022 | - | -$259.00 K(-100.8%) | $29.33 M(-0.9%) |
| Jun 2022 | - | $31.04 M(-2243.4%) | $29.59 M(-2143.4%) |
| Mar 2022 | - | -$1.45 M | -$1.45 M |
| Dec 2021 | $103.25 M(+299.6%) | - | - |
| Dec 2020 | $25.84 M | - | - |
FAQ
- What is Structure Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Structure Therapeutics?
- What is Structure Therapeutics annual CFF year-on-year change?
- What is Structure Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Structure Therapeutics?
- What is Structure Therapeutics quarterly CFF year-on-year change?
- What is Structure Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Structure Therapeutics?
- What is Structure Therapeutics TTM CFF year-on-year change?
What is Structure Therapeutics annual cash flow from financing activities?
The current annual CFF of GPCR is $515.26 M
What is the all time high annual CFF for Structure Therapeutics?
Structure Therapeutics all-time high annual cash flow from financing activities is $515.26 M
What is Structure Therapeutics annual CFF year-on-year change?
Over the past year, GPCR annual cash flow from financing activities has changed by +$63.73 M (+14.11%)
What is Structure Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of GPCR is $615.00 K
What is the all time high quarterly CFF for Structure Therapeutics?
Structure Therapeutics all-time high quarterly cash flow from financing activities is $514.70 M
What is Structure Therapeutics quarterly CFF year-on-year change?
Over the past year, GPCR quarterly cash flow from financing activities has changed by +$1.37 M (+181.24%)
What is Structure Therapeutics TTM cash flow from financing activities?
The current TTM CFF of GPCR is $515.26 M
What is the all time high TTM CFF for Structure Therapeutics?
Structure Therapeutics all-time high TTM cash flow from financing activities is $797.51 M
What is Structure Therapeutics TTM CFF year-on-year change?
Over the past year, GPCR TTM cash flow from financing activities has changed by -$281.01 M (-35.29%)